Putnam Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 1,210,735 shares of REGN stock, worth $923 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

1,210,735

Previous 1,186,406 2.05%

Holding current value

$923 Million

Previous $976 Million 8.91%

% of portfolio

1.46%

Previous 1.53%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $18.9 Million - $21.5 Million	24,329 Added 2.05%	1,210,735 $1.06 Billion
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $11.8 Million - $14.4 Million	17,085 Added 1.46%	1,186,406 $976 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $2.8 Million - $3.32 Million	4,004 Added 0.34%	1,169,321 $840 Million
Q1 2023 May 22, 2023	BUY	$680.49 - $826.97 $32.5 Million - $39.5 Million	47,784 Added 4.28%	1,165,317 $958 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $9.67 Million - $10.5 Million	13,700 Added 1.24%	1,117,533 $806 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $4.4 Million - $5.56 Million	-7,670 Reduced 0.69%	1,103,833 $760 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $8.93 Million - $12 Million	16,292 Added 1.49%	1,111,503 $657 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $148 Million - $173 Million	-248,392 Reduced 18.49%	1,095,211 $765 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $461,414 - $569,653	849 Added 0.06%	1,343,603 $849 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $232 Million - $275 Million	404,567 Added 43.12%	1,342,754 $813 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $134 Million - $158 Million	282,535 Added 43.09%	938,187 $524 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $103 Million - $127 Million	231,463 Added 54.57%	655,652 $310 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $143 Million - $181 Million	-298,334 Reduced 41.29%	424,189 $205 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $13.1 Million - $15.8 Million	23,989 Added 3.43%	722,523 $404 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $12.1 Million - $15.8 Million	24,483 Added 3.63%	698,534 $436 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $66.4 Million - $97.6 Million	197,393 Added 41.41%	674,051 $329 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $130 Million - $179 Million	474,138 Added 18815.0%	476,658 $179 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $5,742 - $6,686	21 Added 0.84%	2,520 $699,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $9.9 Million - $13.7 Million	-33,054 Reduced 92.97%	2,499 $782,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $10.6 Million - $12.5 Million	28,548 Added 407.54%	35,553 $14.6 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $2.01 Million - $2.41 Million	5,986 Added 587.44%	7,005 $2.62 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $42,487 - $49,429	-121 Reduced 10.61%	1,019 $412,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $80.5 Million - $106 Million	-224,510 Reduced 99.49%	1,140 $429,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $97.3 Million - $114 Million	225,650	225,650 $101 Million

Others Institutions Holding REGN

# of Institutions

1,533

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History